Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis
Abstract Chorea-Acanthocytosis (ChAc) is a devastating, little understood, and currently untreatable neurodegenerative disease caused by VPS13A mutations. Based on our recent demonstration that accumulation of activated Lyn tyrosine kinase is a key pathophysiological event in human ChAc cells, we to...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2021-05-01
|
| coleção: | Acta Neuropathologica Communications |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s40478-021-01181-y |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
